Abstract Body

Background: Renal toxicity and other non-AIDS conditions are leading causes of morbidity and mortality in HIV-infected adults in the HAART era. Cystatin C has been proposed as a more sensitive marker of renal function in this population, but may be affected by ongoing inflammation. We aimed to study cystatin C levels and how they correlate with classic markers of renal function and inflammatory factors in a cohort of HIV-infected pediatric patients.

Methods: Multicentre cross-sectional observational study conducted in a cohort of HIV-infected children and adolescents followed-up in 3 pediatric centers in Spain. Renal function was assessed by means of first morning urine protein/creatinine and albumin/creatinine ratios and creatinine-estimated glomerular filtration rates (eGFR), together with the following inflammatory markers: reactive C protein, beta-2-microglobulin and 25(OH)-vitamin D levels. Plasma cystatin C was measured using a turbidimetric inmunoassay (Multigent cystatin C assay; Abbott Diagnostics, Wiesbaden, Germany; normal values <1.38 mg/L). A control group of sex- and age-matched healthy children and adolescents was used.

Results: Overall, 83 HIV-infected patients (51 females, mean age 12.7y) and 49 controls were included. At assessment, mean CD4 cell count was 921/mmcc, 29 patients had a previous AIDS diagnosis, 73 were on HAART (including tenofovir in 28) and HIV viremia was undetectable in 61. No patient presented symptoms consistent with urinary protein loss or renal damage. No differences in renal function and cystatin C levels were observed between patients and controls.
In univariate analysis among HIV-infected patients, higher cystatin C levels were associated with no previous AIDS diagnosis (0.89 vs 0.81 mg/L; p=0.05), previous indinavir exposure (1.11 vs 0.87 mg/L; p=0.02), detectable viral load (0.91 vs 0.87 mg/L; p=0.08) and naïve status (0.96 vs 0.87 mg/L; p=0.07). Significant correlations were also observed between cystatin C and eGFR (r=-0.27; p=0.01) and beta-2-microglobulin (r= 0.569; p< 0.01). In multivariate analysis, adjusted by undetectable viremia (yes/no), eGFR (p=0.014), beta-2-microglobulin levels (p=0.001) and prior use of indinavir (p=0.012) remained as independent risk factors for higher cystatin C values.

Conclusions: In our study, cystatin C values were associated with eGFR and beta-2-microglobulin. This suggests that cystatin C may be useful as a marker of renal function in HIV-infected pediatric patients, independently of ongoing inflammation or viremia.